Related Experiment Videos
Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes
François Curtin1, Diana Elbourne, Douglas G Altman
1Medical Statistics Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1 7HT, UK. francoiscurtin@compuserve.com
Statistics in Medicine
|September 5, 2002
Summary
Pooling binary outcomes from parallel and cross-over trials requires careful consideration of correlation. The marginal odds ratio (OR) method is recommended for combined meta-analysis due to its independence from between-period correlation.
Area of Science:
- Biostatistics
- Clinical Trials
- Meta-Analysis
Background:
- Pooling binary outcomes from parallel and cross-over trials presents statistical challenges.
- Existing methods like Mantel-Haenszel and Peto use joint conditional probabilities, which can be problematic in cross-over designs.
Purpose of the Study:
- To compare different methods for pooling binary outcomes from parallel and cross-over trials.
- To identify the most suitable method for combined meta-analysis of parallel and cross-over trial data.
Main Methods:
- Comparison of odds ratio (OR) estimators derived from joint conditional probabilities versus marginal results in cross-over trials.
- Evaluation of the impact of between-period correlation on OR estimates.
- Assessment of computational similarity between methods for parallel and cross-over trials.
Main Results:
- Joint conditional odds ratio (OR) estimators differ from marginal ORs when between-period correlation exists in cross-over trials.
- Joint conditional ORs cannot be combined with OR estimates from parallel trials under correlation.
- The marginal OR estimate is independent of between-period correlation and adjusts the variance estimate for cross-over correlation.
Conclusions:
- The marginal odds ratio (OR) method is the preferred approach for pooling binary outcomes in combined meta-analyses involving both parallel and cross-over trials.
- This method's independence from between-period correlation and computational similarity across trial designs make it ideal for integrated analysis.